Ronald Peck, M.D.

Ronald Peck, M.D.

Former Chief Medical OfficeratArvinas· In proxies 2021–2023

Pay in FY2023-22% from the year before · Arvinas stock +20.3% the same year

Ronald Peck, M.D. was paid $2.7M in FY2023 (Dec), down 22%. Arvinas stock rose 20.3% that year.

Pay$100 in the stock at the end of FY20 → $48
Pay is from the Summary Compensation Table of each Arvinas proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ArvinasPublic company · 5 yr
    • Former Chief Medical Officer2021 – Present · 5 yrStock in role -91%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?